3 days ago
Dolat Capital Keeps Their Buy Rating on IPCA Laboratories Limited (IPCALAB)
In a report released yesterday, Rashmi Sancheti from Dolat Capital maintained a Buy rating on IPCA Laboratories Limited (IPCALAB – Research Report), with a price target of INR1,604.00. The company's shares closed last Friday at INR1,424.80.
Confident Investing Starts Here:
IPCA Laboratories Limited has an analyst consensus of Hold, with a price target consensus of INR1,435.00.
The company has a one-year high of INR1,757.65 and a one-year low of INR1,060.95. Currently, IPCA Laboratories Limited has an average volume of 6,059.
